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Abstract Human inﬂuenza viruses derive their genes
from avian viruses. The neuraminidase (NA) of the avian
viruses has, in addition to the catalytic site, a separate
sialic acid binding site (hemadsorption site) that is not
present in human viruses. The biological signiﬁcance of
the NA hemadsorption activity in avian inﬂuenza viruses
remained elusive. A sequence database analysis revealed
that the NAs of the majority of human H2N2 viruses
isolated during the inﬂuenza pandemic of 1957 differ
from their putative avian precursor by amino acid sub-
stitutions in the hemadsorption site. We found that the
NA of a representative pandemic virus A/Singapore/1/57
(H2N2) lacks hemadsorption activity and that a single
reversion to the avian-virus-like sequence (N367S)
restores hemadsorption. Using this hemadsorption-positive
NA, we generated three NA variants with substitutions
S370L, N400S and W403R that have been found in the
hemadsorption site of human H2N2 viruses. Each sub-
stitution abolished hemadsorption activity. Although,
there was no correlation between hemadsorption activity
of the NA variants and their enzymatic activity with
respect to monovalent substrates, all four hemadsorption-
negative NAs desialylated macromolecular substrates
signiﬁcantly slower than did the hemadsorption-positive
counterpart. The NA of the 1918 pandemic virus A/Brevig
Mission/1/18 (H1N1) also differed from avian N1 NAs
by reduced hemadsorption activity and less efﬁcient
hydrolysis of macromolecular substrates. Our data indi-
cate that the hemadsorption site serves to enhance the
catalytic efﬁciency of NA and they suggest that, in
addition to changes in the receptor-binding speciﬁcity of
the hemagglutinin, alterations of the NA are needed for
the emergence of pandemic inﬂuenza viruses.
Introduction
Inﬂuenza A viruses carry two surface glycoproteins, the
hemagglutinin (HA) and the neuraminidase (NA) which
recognise the same host cell molecule, sialic acid. HA
mediates virus binding to sialic acid-containing cell-
surface receptors to initiate infection (reviewed in ref.
[28, 42]). NA is an enzyme that cleaves sialic acid from
glycoconjugates on extra-cellular inhibitors, cells and
progeny virions and thus facilitates virus access to receptors
on cell membrane, promotes release of viral progeny and
prevents its receptor-mediated self-aggregation [2, 10, 30,
35]. X-ray analysis of NAs from several inﬂuenza A and B
viruses revealed that the catalytic site is a deep pocket on
the NA surface formed by amino acid residues that are
conserved among NA types and subtypes [4, 11, 41, 49].
Viruses that carried either HA (H3N2, 1968) or both HA
and NA (H1N1, 1918; H2N2, 1957) derived from avian
inﬂuenza viruses caused three inﬂuenza pandemics in the
last century (reviewed in ref. [54]). The 1918 virus is
believed to be an avian-like virus derived in toto from an
unknown animal host [45]. The 1957 pandemic was caused
by a reassortant virus that contained genes of HA, NA and
PB1 from an H2N2 avian virus and the remainder from a
currently circulated human H1N1 virus. The 1968 pan-
demic virus acquired H3 HA and PB1 from an avian virus
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porary human H2N2 virus. Thus, the NAs of both H2N2
and H3N2 human viruses represent descendants of the
avian NA that was introduced into humans in 1957. A shift
of the receptor-binding speciﬁcity of the avian virus HA
from Neu5Aca2-3Gal recognition to Neu5Aca2-6Gal rec-
ognition is thought to be a prerequisite for the generation of
pandemic viruses [25, 26, 47], however, no functional
changes in the avian NAs of 1918 and 1957 viruses have
been identiﬁed so far.
It has been known for some time that the NA of the
avian inﬂuenza viruses has in addition to the catalytic site
a separate sialic acid binding site and displays hemad-
sorption activity which cannot be blocked by the inhibi-
tors of the catalytic site [16, 20, 23]. The amino acid
residues responsible for hemadsorption were identiﬁed by
sequencing monoclonal escape mutants of N9 NA that
lost this activity [53] and by site-directed mutagenesis of
N2 and N1 NAs [16, 20, 34]. The crystal structure of the
complex of the N9 NA with two sialic acid residues
bound to both the catalytic site and the hemadsorption site
was resolved [48]. The hemadsorption site is a shallow
pocket located in the vicinity of the deep catalytic site
and formed by three surface peptide loops. Six residues
on these loops directly interact with the sialic acid residue
in the hemadsorption site (see Fig. 1a, b). With a few
exceptions, ﬁve of these amino acids (367S, 370S, 372S,
400N and 403W) are conserved among the avian virus
NAs of all nine antigenic subtypes [20, 48]. Kobasa et al.
[20] examined representative NAs of most antigenic
subtypes from avian, human and swine viruses. They
found that all avian virus NAs possessed a high level of
hemadsorption activity whereas N1 and N2 NAs of
human viruses displayed much weaker activity. This
ﬁnding correlated with the conservation of the amino
acids forming the hemadsorption site of NA in avian
viruses and a lack of such conservation in human and
swine viruses [20, 48]. Taken together, these notions
suggested that the hemadsorption site of the NA has some
role in virus replication in birds but is either not essential
or disadvantageous for the virus replication in humans.
However, abrogation of the hemadsorption activity of an
avian virus NA by site-directed mutagenesis did not sig-
niﬁcantly affect viral replication in the duck intestine
under experimental conditions [20]. Unlike most avian
viruses, H9N2 viruses from Asian poultry were found to
possess HAs that displayed a human-virus-like receptor
speciﬁcity and NAs that harboured amino acid substitu-
tions in the hemadsorption site [1, 24, 29]. Sequence
analysis revealed that mutation of the NA hemadsorption
site of H9N2 viruses resulted from a positive selective
pressure to change suggesting that a loss of the site
increased virus ﬁtness in land-based poultry [29].
Neither the function of the NA hemadsorption site in
avian viruses, nor the exact time and mechanisms of its
disappearance after interspecies transmission are known.
It was noticed that substitution S370L reduced hemad-
sorption activity of avian N2 NA with concomitant 50%
reduction of the NA enzymatic activity [20]. However,
several other single or multiple amino acid substitutions
in N1 and N2 NAs abolished hemadsorption activity
without apparent effects on enzymatic activity [16, 53].
These results argued against a consistent role of the
hemadsorption site in the catalytic activity of the NA. A
possible role of this site in the virus attachment to
receptors in birds was suggested [38, 48]. No evidence in
support of this hypothesis is available; moreover, failure
of antibodies to NA to inhibit virus attachment [23] dis-
agrees with it.
In this study, we wished to specify the functional role of
the NA hemadsorption site. To address this question, we
generated several variants of the NA of the pandemic virus
strain A/Singapore/1/57 (H2N2) that differed from each
other by amino acid substitutions in the key positions of the
hemadsorption site and by hemadsorption activity. We
analyzed the enzymatic activity of the NAs expressed in
Cos-7 cells and of corresponding recombinant viruses and
concluded that the hemadsorption site serves to enhance
the catalytic activity of NA.
Materials and methods
Viruses, cells and reagents
Inﬂuenza virus A/Singapore/1/57 (H2N2) was from the
repository of the Institute of Virology, Marburg. Madin–
Darby canine kidney (MDCK) and African Green Monkey
Kidney Fibroblast (Cos-7) cells were cultured in Dul-
becco’s modiﬁed Eagle’s medium supplemented with 10%
FCS and 1% glutamine. 20-(4-methylumbelliferyl)-N-acetyl-
neuraminic acid (MU-NANA), 30-sialyl-N-acetyllactos-
amine (3SLN), 60-sialyl-N-acetyllactosamine (6SLN) and
bovine fetuin were obtained from Sigma (St. Louis, MO,
USA). Peroxidase-conjugated anti-rabbit antibodies were
from DAKO (Hamburg, Germany). Human airway mucins
were collected from the apical surface of differentiated
human tracheo-bronchial epithelial cultures prepared as
described previously [14, 30]. Synthetic sialylglycopoly-
mers 3SL-PAA and 6SLN-PAA, which contained 20 mol%
of 30-sialyllactose (3SL) and 6SLN, respectively, attached
to a soluble polyacrylamide carrier [9] were kindly pro-
vided by Nikolai Bovin and Alexander Tuzikov, Institute
of Bio-Organic Chemistry, Moscow, Russia. pHW2000
plasmid [17] was kindly provided by Eric Hoffmann and
Robert Webster, St. Jude Children’s Research Hospital,
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provided by Wolfgang Garten, Institute of Virology,
Marburg.
Cloning and site-directed mutagenesis
The full-length gene of the NA of A/Singapore/1/57
(H2N2) virus (SG/57) was ampliﬁed by RT-PCR from
isolated RNA and ligated into the pHW2000 plasmid using
BsmBI restriction sites as described previously [17, 18].
Amino acid substitutions in the hemadsorption site of the
NA-pHW2000 plasmid were introduced using Quikchange
site directed mutagenesis kit [Stratagene, (La Jolla, CA,
USA)]. The coding sequences of the original and mutated
NAs were subcloned into pCAGGS/MCS plasmid [20, 33]
using XhoI/SmaI restriction sites. The full length NA gene
of A/Brevig Mission/1/18 (H1N1) virus (Genbank
AF250356) was synthesized commercially (Genscript
Corporation, Piscataway, NJ, USA). Plasmids pHH21-
FPV-NA and polISapI-Os/Italy-NA encoding NA genes of
A/Chicken/FPV/Rostock/34 (H7N1) [50] and A/Ostrich/
Italy/984/00 (H7N1) were provided by Ralf Wagner and
Bjoern Keiner, Institute of Virology, Marburg. The N1 NA
genes were PCR-ampliﬁed and cloned into pCAGGS/MCS
vector using EcoRI/NotI restriction sites. The coding
sequence of the M gene of A/Hong Kong/1/68 (H3N2) was
subcloned from pHW2000-M plasmid [25] into XhoI/SmaI
sites of the pCAGGS/MCS plasmid. The identities of all
plasmids were conﬁrmed by sequencing.
Assays of expression level and hemadsorption activity
of the NAs
Monolayers of Cos-7 cells grown in 96-well plates were
transfected with pCAGGS-NA plasmids using Lipofect-
amine 2000 (Invitrogen, Karlsruhe, Germany). Empty
pCAGGS plasmid was used for a mock-transfected control.
Forty-eight hours after transfection, the cell monolayers
were ﬁxed with 4% paraformaldehyde for 20 min at 4C
and incubated with serial twofold dilutions of rabbit anti-
H9N2 virus antibodies, followed by peroxidase-conjugated
anti-rabbit IgG antibodies. Levels of bound antibody were
determined with the peroxidase substrate o-phenylenedi-
amine and quantiﬁed by measuring absorbance at 490 nm.
To calculate the relative expression level of the NAs with
respect to that of the NA of A/Singapore/1/57 (as presented
in the Table 1), we used ratios of corresponding absor-
bencies at anti-H9N2 antibody dilution 1/1,600 corrected
for the absorbance of mock-transfected cells.
The hemadsorption activities of the NAs were deter-
mined in parallel with the assay of NA expression levels
using replicate transfected cultures of Cos-7 cells 48 h
post transfection. The cell monolayers were incubated
with 1% suspensions of either chicken or human
Fig. 1 Hemadsorption site of the NA and its alteration in the H2N2
pandemic viruses. a Molecular surface of N9 NA tetramer with sialic
acids bound to the catalytic (green) and hemadsorption (yellow) sites
(1MWE, [48]). b Positions of the three peptide loops forming the
hemadsorption site are indicated. The side chains of amino acids
contacting sialic acid are shown and labelled using the N2 numbering
system. The carbon atoms of the protein and sialic acid are coloured
yellow and grey, respectively. Nitrogens are blue and oxygens are red.
Dashed lines depict polar contacts. The models in Figs. 1 and 5 were
generated using DeLano Scientiﬁc PyMOL release 0.99 (DeLano,
W.L. The PyMOL Molecular Graphics System, http://pymol.
sourceforge.net). c Amino acid substitutions in the NA hemadsorp-
tion site of human viruses with respect to the closely related avian
virus A/Duck/Hong Kong/7/75 (H3N2). All non-redundant NA
sequences of H2N2 viruses from 1957 to 1958 and few representative
sequences of the viruses isolated after 1958 are shown. Amino acids
contacting sialic acid in the hemadsorption site are highlighted. The
minimum evolution phylogenetic tree was build for nucleotide
sequences using MEGA4 software [44]
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123erythrocytes for 30 min at 4C. Non-bound erythrocytes
were removed by washing, and bound erythrocytes were
stained using diaminobenzidine peroxidase substrate
solution. The cultures were ﬁxed with methanol, and
nuclei of Cos-7 cells were stained with 1% Alcian Blue in
3% acetic acid. To quantify hemadsorption activity, we
determined the average number of red blood cells
adsorbed per ten Cos-7 cells by analysis of at least 250
Cos-7 cells per replicate culture under an Olympus IMT-2
microscope with a 209 objective.
Enzymatic activity of expressed NA
Monolayers of NA-expressing Cos7-cells in 96 well plates
were incubated with sialic acid-containing substrates in
Ca-TBS buffer (4 mM CaCl2, 0.02 M Tris, 0.85% NaCl;
pH 7) at 37C. Hydrolysis of MU-NANA was quantiﬁed by
measuring ﬂuorescence of released 4-methylumbelliferone
as described previously [27]. Sialic acids liberated from
non-ﬂuorescent substrates were determined at different
time points (from 5 min to 6 h) by thiobarbituric acid assay
[43, 52]. Speciﬁc NA activities (pmole sialic acid released
per minute per culture) were calculated in the linear range
of released sialic acid-versus-time plots.
Generation of recombinant viruses
Recombinant viruses rgHAD- and rgHAD? which con-
tained, respectively, the gene of hemadsorption-negative
(HAD-) wild-type SG/57 NA and its hemadsorption-
positive (HAD?) N367S mutant were generated by using
the eight plasmid reverse genetic system as described
previously [17]. The seven other genes of the viruses were
derived from the 1968 pandemic virus A/Hong Kong/1/68
(H3N2) because corresponding plasmids were already
available from our previous study [25]. The viruses were
plaque puriﬁed, grown in MDCK cells and stored in ali-
quots at -80C. The identities of all viral genes were
conﬁrmed by sequencing.
Enzymatic activity of recombinant viruses
The stocks of recombinant viruses rgHAD? and rgHAD-
were analyzed for their content of the NA and M1 proteins
by SDS-PAGE under non-reducing conditions and
immuno-blotting using anti-H9N2 inﬂuenza virus anti-
bodies, peroxidase-labelled secondary antibodies and ECL
substrate (Pierce, Rockford, IL, USA). To study NA
enzymatic activities, the stocks were adjusted to equal NA
content and incubated with sialic acid-containing sub-
strates. The liberation of sialic acid was quantiﬁed at dif-
ferent time points as described above for cell-expressed
NAs. To determine the ability of the viral NA to destroy
sialic acid receptors on cells, we used a hemagglutination-
elution assay. Serial twofold dilutions of viruses in 50 ll
PBS in U-bottomed microtiter plates were incubated for
1 h at 4C with 50 ll of 0.5% suspensions of human
erythrocytes. Disaggregation of virus-agglutinated cells
was monitored at 37C.
Adsorption of desialylated/resialylated red blood cells
Human erythrocytes that carry either Neu5Aca2-3Gal or
Neu5Aca2-6Gal moieties were prepared as described pre-
viously [13, 36]. In brief, 100 ll of 10% human red blood
cells were desialylated using 100 mU Vibrio cholerae
sialidase (Behring AG, Marburg, Germany) and resialy-
lated for 60 min at 37C using either 0.5 mU rat a2-3-(N)-
Table 1 Hemadsorption and enzymatic activities of N2 neuraminidases expressed in Cos-7 cells
NA
a Expression
relative
to SG/57
b
Hemadsorption
activity (CRBCs per
ten Cos-7 cells)
Enzymatic activity (pmole sialic acid released per minute per culture)
MU-NANA
0.1 mM
3SLN
0.1 mM
6SLN
0.4 mM
Fetuin
0.3 mM
Human mucin
0.1 mM
3SL-PAA
0.1 mM
6SLN-PAA
0.4 mM
SG/57 1 0.68 (0.60) 230 (44) 280 (26) 56 (5.4) 110 (27) 4.9 (1.2) 160 (20) 30 (6.3)
N367S (av-like) 0.99 (0.11) 72 (15)* 230 (37) 270 (29) 59 (4.3) 180 (32)* 25 (1.0)* 340 (49)* 130 (22)*
N367S-S370L 1.0 (0.09) 0.39 (0.33) 230 (36) 210 (14)* 49 (7.3) 96 (35) 4.3 (1.4) 110 (15)* 27 (5.3)
N367S-N400S 0.99 (0.14) 0.48 (0.38) 230 (36) 260 (41) 58 (5.8) 130 (19) 5.0 (1.3) 180 (27) 35 (8.9)
N367S-W403R 0.98 (0.09) 0.58 (0.42) 220 (31) 290 (35) 54 (14) 120 (14) 5.5 (0.9) 170 (23) 31 (3.3)
All data represent mean values and SD (in parenthesis) of three to four independent experiments with assay performed in duplicate (n = 6–8).
Hemadsorption activity is expressed as number of chicken red blood cells (CRBCs) adsorbed per ten Cos-7 cells (see Fig. 2). Concentrations of
bound sialic acid used in the assay are indicated under the name of corresponding substrate
* P\0.05 (unpaired two-sided t test versus SG/57)
a NA designations reﬂect sequence differences with SG/57
b Determined by cell ELISA
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(Calbiochem, Bad Soden, Germany) in the presence of
1.5 mM CMP-sialic acid (Sigma, St. Louis, MO, USA).
Resialylated erythrocytes were used to perform hemad-
sorption assay as described above.
Results
The NAs of pandemic H2N2 virus strains from 1957
carry amino acid substitutions in the hemadsorption site
The NA gene of the H2N2/1957 pandemic virus originated
from an avian precursor; this gene was later inherited by
the H3N2/1968 pandemic virus [40, 54]. Previous studies
indicated that the NAs of H2N2 and H3N2 human viruses
isolated after 1966 had multiple amino acid changes in the
hemadsorption site and lacked hemadsorption activity [20,
29, 34, 48]. However, it remained obscure whether changes
in the structure and activity of the hemadsorption site had
already occurred at the onset of the H2N2 pandemic.
To address this question, we analyzed the N2 NA
sequences currently available from the National Center
for Biotechnology Information Inﬂuenza Virus Resource
(http://www.ncbi.nlm.nih.gov/genomes/FLU/FLU.html).
With the exclusion of two virus strains, all sequenced
human pandemic viruses isolated in 1957 and 1958 har-
boured substitutions in the conserved positions of the
hemadsorption site, either S367N, or S370L (Fig. 1c). In
the structural model of the N9 NA complex with two sialic
acid molecules [48], the side chain hydroxyls of 367S and
370S of the protein form hydrogen bonds with the carboxyl
oxygen and the 8-OH group of the sialic acid, respectively
(Fig. 1b). Substitutions S367N and S370L affect these
hydrogen bonds and, in addition, might create sterical
obstacles for the accommodation of the sialic acid in the
hemadsorption site. Three viruses from 1957 contained in
addition to the 367/370 substitution a second change
(D369E or P431Q). Neither 369 nor 431 of the N9 NA
contacts the bound sialic acid residue. However, the side
chain of D369 faces towards the solvent [49] and could
potentially interact with either the sialic acid or the pen-
ultimate sugar residue in the hemadsorption site of N2 NA.
Substitution P431Q could change the orientation of the 430
loop and affect the positions of residues 432 and 403 that
interact with the sialic acid.
A/Leningrad/57 and A/Adachi/2/57 lacked substitutions
in any of the six positions that contact sialic acid in the
hemadsorption site. The HA of the former virus has avian-
virus-like receptor speciﬁcity and is therefore believed to
be a mutant derived in the laboratory by passaging in
embryonated hen’s eggs [26]. The sequence of the HA and
passage history of the second virus are not known.
Two virus isolates from 1958, A/Malaya/16/58 and
A/Albany/24/58, had substitutions N400S and N400K,
respectively. Amino acids in this position are not con-
served among the NAs of different subtypes [20, 48],
however, both main chain and side chain atoms of 400N
interact with the sialic acid residue in the N9 NA
(Fig. 1b), suggesting that substitutions in this position
could affect the stability of the complex. All sequenced
viruses isolated after 1958 harboured the S370L substitu-
tion and accumulated additional substitutions in the
hemadsorption site. In particular, the substitution W403R
that occurred after 1965 could affect interactions of the
protein with the 5N-acetyl moiety of the sialic acid
(Fig. 1b). As a result, ﬁve substitutions in the hemad-
sorption site (S370L, N400S, N401D, W403R, P431K)
separate the NA of the late H2N2 virus isolate A/Tokyo/3/
67 and the NA of H3N2 pandemic virus A/Hong Kong/1/
68 from a putative avian precursor.
Effects of amino acid substitutions in the second sialic
acid binding site on hemadsorption and enzymatic
activities of N2 NA
To assess phenotypic effects of the substitutions in the
hemadsorption site of human H2N2 virus, we focused on
the NA of the H2N2 pandemic virus A/Singapore/1/57.
The hemadsorption site of this NA differs from that of a
putative avian ancestor by a single amino acid substitution
S367N (Fig. 1c). As reported previously [19, 21], the NA
of SG/57 displayed high enzymatic activity, preferentially
cleaved a2-3-linked sialic acids and supported replication
of an avian reassortant virus in the duck intestine. Thus,
apart from the substitution in position 367, the NA of SG/
57 represents a typical avian virus NA. We ampliﬁed the
full-length NA gene of SG/57 by RT-PCR from isolated
RNA, cloned the cDNA into the mammalian expression
plasmid pCAGGS/MCS and introduced a single-point
substitution, N367S, that restored the sequence of the avian
hemadsorption site. Using this avian-virus-like NA, we
prepared three NA variants with amino acid substitutions
S370L, N400S and W403R, respectively (Table 1). This
set of ﬁve NAs modelled the NA hemadsorption site of the
putative avian precursor of the 1957 pandemic viruses
(variant N367S) and of distinct H2N2 viruses that circu-
lated in the ﬁrst years of the pandemic and afterwards
(Fig. 1c).
To study properties of the NA variants, we transfected
cultures of Cos-7 cells with pCAGGS-NA plasmids. Forty-
eight hours later, we analyzed the cells for NA expression
level, hemadsorption and enzymatic activities. All NAs
were expressed in the same amount on the cell surface
(Table 1). Human and chicken erythrocytes efﬁciently
bound to the cells expressing the avian-virus-like NA
Hemadsorption activity of inﬂuenza virus neuraminidase 949
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the other three NAs with human-virus-like amino acid
substitutions in the hemadsorption site showed signiﬁcant
hemadsorption (Fig. 2; Table 1). These data suggested that
the majority of the earliest available virus isolates from the
1957 pandemic, as well as subsequent isolates, lacked high
hemadsorption activity of avian NAs owing to mutations in
the hemadsorption site.
We next compared enzymatic activities of NAs expres-
sed in Cos-7 cells using several substrates (Table 1). The
low molecular mass substrates 20-(4-methylumbelliferyl)-
N-acetylneuraminic acid (MU-NANA), 30-sialyl-N-acetyl-
lactosamine (3SLN) and 60-sialyl-N-acetyllactosamine
(6SLN) contained one sialic acid residue per molecule. The
macromolecular substrates fetuin, human airway mucin,
synthetic sialylglycopolymers 3SL-PAA and 6SLN-PAA
[9] harboured multiple copies of sialyloligosaccharide
moieties. Fetuin and mucin contained both 3-linked and
6-linked sialic acid residues, whereas sialylglycopolymers
were monospeciﬁc and contained either 3-linked (3SL-
PAA) or 6-linked (6SLN-PAA) residues. All ﬁve NAs
cleaved 3SLN much faster than 6SLN in accord with the
known linkage speciﬁcity of avian virus NAs [5, 16, 19].
Four NAs (SG/57, N367S, N367S-N400S and N367S-
W403R) desialylated each of the monovalent sialosides
with identical efﬁciency, indicating that amino acid sub-
stitutions in the hemadsorption site had no effect on the
enzymatic activity of the adjacent catalytic site. The variant
N367S-S370L hydrolyzed 3SLN with about 30% lower
efﬁciency than did other NAs. A similar effect was reported
by Kobasa and colleagues [20] who found that substitution
S370L decreased enzymatic activity of avian N2 NA
against MU-NANA. Despite a lack of correlation between
NA hemadsorption activity and hydrolysis of monovalent
sialosides, all four hemadsorption-negative NAs desialy-
lated macromolecular substrates 2–5 times less efﬁciently
than did the hemadsorption-positive avian-virus-like NA
variant N367S. These ﬁndings indicated that amino acid
substitutions in the hemadsorption site of 1957 pandemic
viruses resulted in reduced enzymatic activity as compared
to the putative avian precursor. Interestingly, in most
instances, the reduction was not caused by a direct effect
of the mutation on the function of the adjacent catalytic
site.
Fig. 2 Hemadsorption activity of N2 neuraminidases. Cos-7 cells
were transfected with pCAGGS-NA plasmids coding for either SG/57
NA or its variants with indicated amino acid substitutions. Empty
pCAGGS plasmid was used as a control (mock). Forty-eight hours
post transfection, the cells were incubated with chicken (left panel)
and human (right panel) erythrocytes, which are commonly used to
characterize binding speciﬁcity of inﬂuenza viruses. The cells were
stained and photographed using Olympus IMT-2 microscope
equipped with Nikon DS-2Mv camera. Objective, 209. Data are
representative of ﬁve or more independent experiments
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hemadsorption-positive and hemadsorption-negative
NAs
To corroborate the results obtained in the experiments with
expressed NAs, we tested the effect of the NA hemad-
sorption activity on the catalytic activity in the context
of complete virus particles. Using the 8-plasmid reverse
genetics system [17], we generated two recombinant
viruses, rgHAD- and rgHAD?, which contained the
hemadsorption-negative NA of SG/57 and its hemadsorp-
tion-positive mutant N367S, respectively. The seven other
gene segments of each virus were derived from the 1968
pandemic virus A/Hong Kong/1/68 (H3N2) [25]. We
determined the ratio of NA to matrix protein in the viruses
by immunoblotting. No differences were found between
rgHAD- and rgHAD? (Fig. 3a), indicating that amino
acid 367 had no effect on NA incorporation into virions.
Based on immunoblotting analysis, we adjusted viral stock
suspensions to identical NA concentrations (Fig. 3a) and
compared their enzymatic activity (Fig. 3b). The pattern of
viral enzymatic activities agreed with that observed in the
case of NAs expressed in Cos-7 cells. Thus, viruses did not
differ in their capacity to hydrolyze monovalent substrates
MU-NANA, 3SLN and 6SLN, however, the virus with
hemadsorption-negative NA desialylated macromolecular
substrates signiﬁcantly more slowly than did rgHAD?.
To compare the ability of the NAs to cleave sialic acid
from receptors expressed on the cell surface, we studied
virus elution from human erythrocytes. We incubated the
viruses with erythrocytes for 1 h at 4C and monitored
disaggregation of virus-agglutinated cells at 37C. The
viruses standardized with respect to their content of NA
and M proteins (Fig. 3a) displayed identical hemaggluti-
nation activity at 4C (Fig. 3c, top panel). Complete dis-
aggregation typically occurred between 6 and 8 h of
incubation in the case of rgHAD? (Fig. 3c, bottom panel)
and between 24 and 48 h in the case of rgHAD- (data not
shown).These experiments indicated that the virus with
hemadsorption-negative NA destroyed receptors on red
blood cells more slowly than did its hemadsorption-posi-
tive counterpart.
Based on these data, we conclude that the presence of
the functional hemadsorption site enhances the capacity of
the virus-associated NA to remove sialic acid from both
soluble macromolecular substrates and cells.
Hemadsorption site binds to both a2-3-linked
and a2-6-linked sialic acids
To characterize binding speciﬁcity of the hemadsorption
site with respect to two major natural sialic acid determi-
nants (Neu5Aca2-3Gal and Neu5Aca2-6Gal), we employed
human erythrocytes that were desialylated using V. chol-
erae sialidase and then resialylated using either a2-3- or
a2-6-sialyltransferases. As expected, desialylated erythro-
cytes lost their ability to bind to Cos-7 cells expressing
hemadsorption-positive NA variant N367S (Fig. 4). Resi-
alylation of erythrocytes partially restored their binding
although modiﬁed erythrocytes bound less efﬁciently than
native red blood cells. It seems likely, that reduced
hemadsorption activity of resialylated cells was at least
partially determined by reduced levels of incorporation of
sialic acid as compared to that of native erythrocytes [36].
However, as both a2-3- and a2-6-resialylated erythrocytes
showed substantial hemadsorption activity, we conclude
that the hemadsorption site of the NA can bind to sialic
acids attached to the penultimate sugar chain by either
linkage type.
To understand the molecular basis for the ability of the
hemadsorption site to bind to both 3-linked and 6-linked
sialic acids, we compared the available crystal structure of
the hemadsorption site of N9 NA [48] with that of the
receptor-binding site of H3 HA [15] (Fig. 5). In the case of
HA, amino acid 226 on the 220-loop and amino acid 190
on the 190-helix are known to interact with asialic parts
of 3-linked and 6-linked receptors and to be primarily
responsible for the linkage recognition (see reviews
[28, 42]). There is no structural equivalent of the 190-helix
in the hemadsorption site of the NA. Furthermore, the
370-loop of NA is located in a relatively low position of
the hemadsorption site as compared to the corresponding
220-loop of the receptor-binding site of HA. For example,
the distance between the glycosidic oxygen of the bound
sialic and the closest amino acid in the receptor-binding
site of the HA (glutamine in position 226) is 3.8 A; the
corresponding distance to the closest amino acid in the
second sialic acid binding site of the NA (position 369) is
about 2 A longer. Thus, the ability of the hemadsorption
site to accommodate both a2-3- and a2-6-linked sialic
acids can be explained by the lack of close amino acid
counterparts for the interaction with the penultimate to
sialic acid saccharide residue(s).
Hemadsorption and enzymatic activities of the NA
of the 1918 pandemic virus
The N1 NA of human inﬂuenza viruses originates from the
NA of the virus that caused the pandemic in 1918 [39]. The
earliest tested human H1N1 virus isolates, A/PR8/34 and
A/Rome/49, showed weak, if any, hemadsorption activity
[20]. To characterize properties of the 1918 NA, we syn-
thesized the NA gene of A/Brevig Mission/1/18 (H1N1)
using the sequence determined by Reid and colleagues [39]
(Genbank AF250356). We compared hemadsorption and
catalytic activities of this NA with those of two N1 NAs of
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and A/Ostrich/Italy/984/00 (H7N1) (Os/Italy) using assays
with transfected Cos-7 cells. The FPV NA was chosen
because it is close to the 1918 NA both phylogenetically
[39] and by the time of circulation; the Os/Italy NA rep-
resented a more distant NA. The expression levels of three
N1 NAs on the cell surface were identical in these exper-
iments as judged by the results of cell ELISA with anti-
bodies against FPV (data not shown). The NA of 1918
virus displayed substantial hemadsorption with human
erythrocytes, although the level of the hemadsorption
activity was reproducibly lower than that of avian N1 NAs
(Fig. 6). The 1918 NA showed much weaker hemadsorp-
tion with chicken erythrocytes (ﬁve to ten times lower than
avian NAs). Thus, similar to the NAs of 1957 pandemic
viruses, the NA of 1918 virus had reduced hemadsorption
activity. However, in the case of 1918 NA the reduction
was less pronounced than in the case of 1957 NA.
The enzymatic activity of 1918 NA, when assayed with
3SLN as substrate, was identical to that of FPV NA and
about 30% lower than that of the NA of Os/Italy (Table 2).
Interestingly, the 1918 NA desialylated 6SLN two times
Fig. 3 Neuraminidase activity of the recombinant viruses rgHAD-
and rgHAD?. Viral suspensions were adjusted to the same NA
content (a) and compared for their enzymatic activity with respect to
soluble substrates (b) and cells (c). Data are representative of ﬁve or
more independent experiments. a Western blot analysis of rgHAD-
(lane 1) and rgHAD? (lane 2) using anti-H9N2 inﬂuenza virus
antibodies. Lysates of 293T cells transfected with pCAGGS plasmids
expressing M1 protein of A/Hong Kong/1/68 (lane 3) and NA of
A/Singapore/1/57 (lane 4) were included as controls. b rgHAD-
(blue) and rgHAD? (red) were incubated with substrates containing
0.1 mM sialic acid at 37C, and concentrations of released sialic acid
were determined at different time points. To account for substrate-
speciﬁc differences in viral neuraminidase activity, 20-fold lower
virus concentration was used in the case of 3SLN, 3SL-PAA and
MU-NANA than in the case of other four substrates. Mean values and
SD of two replicate samples in one experiment are shown. c Serial
twofold dilutions of the viruses were incubated with equal volumes of
0.5% human erythrocytes at 4C for 1 h (top panel), followed by
incubation at 37C for 8 h (bottom panel)
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123faster than did avian N1 NAs. All three NAs cleaved
6SLN-PAA with identical efﬁciency; however, the 1918
NA displayed a reduced activity with respect to the three
other polyvalent substrates tested. To compare the capacity
of N1 NAs to discriminate between monovalent and
polyvalent substrates, we calculated ratios of speciﬁc
enzymatic activities 3SL-PAA/3SLN and 6SLN-PAA/
6SLN (Table 2). Both ratios were at least twofold smaller
in the case of the 1918 NA than in the case of the avian
NAs, indicating that the polyvalency of the substrate has a
lower impact on the catalytic efﬁciency of the 1918 NA.
These results agree with the data on N2 NA mutants which
suggest that hemadsorption activity of the NA enhances its
catalytic activity with respect to polyvalent macromolec-
ular substrates without changing hydrolysis rates of
monovalent substrates.
Discussion
In this study, we addressed a long-standing question about
the functional signiﬁcance of the hemadsorption site pres-
ent in the NA of avian inﬂuenza viruses [20, 23, 48]. To
this end, we cloned the hemadsorption-negative NA of the
human pandemic virus A/Singapore/1/57 (H2N2) and
generated its hemadsorption-positive avian-virus-like var-
iant as well as three other hemadsorption-negative human-
virus-like variants with single amino acid substitutions at
different positions of the hemadsorption site. We next used
this panel of ﬁve NA variants to determine how substitu-
tions that abolish hemadsorption activity will affect the
enzymatic activity of the NA. All hemadsorption-negative
variants turned out to have a signiﬁcantly lower enzymatic
activity than the hemadsorption-positive counterpart with
respect to all macromolecular substrates tested. Impor-
tantly, three out of four hemadsorption-negative variants
(S367N, N400S and W403R) did not differ from the
hemadsorption-positive NA in their capacity to hydrolyze
low molecular weight monovalent sialosides. This ﬁnding
indicated that the reduced catalytic activity of these vari-
ants resulted primarily from the loss of the hemadsorption
activity and not from direct effects of the substitutions in
the hemadsorption site on the structure of the adjacent
catalytic site.
SimilarlytoinﬂuenzavirusNA,somebacterialNAs,such
as the NAs from V. cholerae, Clostridium perfringens and
Micromonospora viridifaciens have lectin domains in addi-
tion to the catalytic domain. For example, the N-lectin-like
Fig. 4 NA hemadsorption to native and modiﬁed erythrocytes. Cos-7
cells expressing the hemadsorption-positive NA variant N367S were
probed with native human erythrocytes, erythrocytes desialylated
with V. cholerae sialidase, and erythrocytes resialylated using a2-3-
and a2-6-sialyltransferases. Data show mean numbers of red blood
cells attached per ten Cos-7 cells and are representative of three
independent experiments
Fig. 5 Comparison of the structures of the NA hemadsorption site of
the N9 NA with bound sialic acid [48] and of the HA receptor-binding
site of A/duck/Ukraine/63 (H3N8) with bound Neu5Aca2-3Gal
disaccharide [15]. The ligands are shown as stick models. Hemad-
sorption site (yellow) and receptor-binding site (green) are superim-
posed over the bound sialic acid residues. Positions of peptide loops
forming the sites are indicated
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of these lectin domains are not yet understood, but it is
believed that they increase the catalytic efﬁciency of the
enzymes (see ref. [31, 32] and references therein). We pro-
vide here direct experimental support to this hypothesis by
demonstrating that an inﬂuenza virus NA with a functional
hemadsorption site has a higher enzymatic activity than its
hemadsorption-negative single-point mutants. Thobhani
etal.[46]reportedthatbacterial NAs,which haveadditional
lectin domains, hydrolyze polyvalent substrates with sig-
niﬁcantly greater catalytic efﬁciency than corresponding
monovalent sialosides. The authors explained this effect by
enhancedafﬁnityofsuchNAsforpolyvalentsubstrates.Our
results are consistent with this mechanism. We therefore
postulate that the hemadsorption site of inﬂuenza virus NA
serves to enhance the catalytic efﬁciency of the NA by
binding natural multivalent substrates and thus recruiting
and keeping them in the vicinity of the enzymatic site.
Hausmann et al. [16] assayed enzymatic activity of N1
NA using 30-sialyllactose and 60-sialyllactose and found
that site-directed mutations of the hemadsorption site had
no effect. Our data explains the failure of this and other
previous studies [20, 53] to uncover the functional role of
the NA hemadsorption site as neither study used polyvalent
substrates. Bousse, Takimoto et al. [7, 8, 56] discovered
recently that paramyxoviruses Newcastle disease virus
(NDV) and Sendai virus have a second sialic acid binding
site on their hemagglutinin–neuraminidase (HN) protein.
They demonstrated that amino acid substitutions in these
sites of either virus have no effect on the NA activity
assayed using 30-sialyllactose. It will now be interesting to
test, whether the second binding site on the HN of para-
myxoviruses could facilitate desialylation of multivalent
substrates.
Two earlier reports revealed that erythrocytes bound to
hemadsorption-positive N9 and N1 NAs could not be
released by the viral NA activity, but were released by
broadly active bacterial sialidases [3, 16]. These data
suggested that the hemadsorption site can bind to an
unidentiﬁed species or linkage of sialic acid that is not
sensitive to cleavage by the catalytic site of the NA. The
N1 NA was previously found to bind to both 3-linked and
6-linked receptors [16]. We have shown here that the N2
subtype NA also binds to both linkage types. Analysis of
the structural features of the NA hemadsorption site
(Fig. 5) explains the inability of the hemadsorption site to
differentiate between the 6- and 3-linked sialic acids and
predicts that this site can have a relatively broad binding
speciﬁcity. The biological signiﬁcance of these ﬁndings
remains to be determined. In any case, binding to non-
cleavable substrate moieties does not seem to be a
Fig. 6 Hemadsorption activity of N1 neuraminidases. Cos-7 cells
were transfected with pCAGGS-NA plasmids coding for the neuram-
inidases of A/Brevig Mission/1/18 (H1N1), A/chicken/FPV/Rostock/
34 (H7N1) and A/Ostrich/Italy/984/99 (H7N1). pCAGGS plasmids
expressing N2 NAs of SG/57 and its hemadsorption-positive mutant
(N367S) were used as negative and positive controls, respectively.
Forty-eight hours post transfection, the cells were probed with chicken
(closed bars) and human (hatched bars) erythrocytes. Data are mean
values and SD of replicate samples in one experiment representative of
ﬁve independent experiments. The values of hemadsorption activity of
the 1918 NA differ from corresponding values of each other NAs
tested (P\0.05, unpaired two-sided t test)
Table 2 Enzymatic activities of N1 neuraminidases expressed in Cos-7 cells
NA Enzymatic activity (pmole sialic acid released per minute per culture) Relative enzymatic activity
a
3SLN
0.1 mM
6SLN
0.4 mM
Fetuin
0.3 mM
Human mucin
0.1 mM
3SL-PAA
0.1 mM
6SLN-PAA
0.4 mM
3SL-PAA/
3SLN
6SLN-PAA/
6SLN
1918 300 (16) 86 (6.2) 90 (6.1) 3.2 (0.3) 120 (22) 67 (7.7) 0.41 (0.05) 0.78 (0.01)
FPV 310 (43) 37 (7.9)* 120 (11)* 4.6 (0.8)* 230 (28)* 76 (2.4) 0.75 (0.15)* 1.72 (0.09)*
Os/Italy 410 (23)* 34 (11)* 140 (13)* 5.3 (0.6)* 300 (43)* 86 (16) 0.74 (0.09)* 2.87 (0.24)*
All data are mean values and SD (in parenthesis) of two to four independent experiments with assay performed in duplicate (n = 4–8).
Concentrations of bound sialic acid used in the assay are indicated under the name of corresponding substrate
* P\0.05 (unpaired two-sided t test versus 1918 NA)
a Ratio of speciﬁc enzymatic activities determined with indicated polyvalent and monovalent substrates
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123prerequisite for the hemadsorption-mediated enhancement
of the catalytic efﬁciency, as the enhancement effect was
observed in the case of mono-speciﬁc sialylglycopolymers
3SL-PAA and 6SLN-PAA (Fig. 3b) that do not carry non-
cleavable sialic acid residues.
In our experiments with recombinant viruses, the virus
with hemadsorption-positive NA did not display a higher
hemagglutinating activityandslower elution from redblood
cells than did the hemadsorption-negative counterpart.
These results indicate either that the hemadsorption site of
the NA doesnotsigniﬁcantly contribute tothe HA-mediated
binding to cellular receptors or that the hemadsorption-
dependent enhancement of receptor cleavage outperforms
the hemadsorption-mediated enhancement of attachment.
Thus, our data do not support the hypothesis that the
hemadsorption site of inﬂuenza virus NA plays a signiﬁcant
role in the virus attachment to target cells [38, 48].
Two inﬂuenza pandemics in the last century were
caused by viruses that derived both HA and NA from avian
inﬂuenza viruses (H1N1, 1918; H2N2, 1957) (reviewed in
ref. [40, 54]). A shift of the receptor-binding speciﬁcity of
the HA from Neu5Aca2-3Gal recognition to Neu5Aca2-
6Gal recognition is believed to be essential for the emer-
gence of these pandemic viruses [25, 26, 47], whereas
functional changes in their NAs have not been identiﬁed.
For example, it was known that the N2 NA of human
viruses isolated after 1967 harboured substitutions in the
hemadsorption site and lacked hemadsorption activity [20,
34], however, due to a lack of sequencing and phenotypic
data it was not clear what happened with the hemadsorp-
tion activity of the N2 NAs in the ﬁrst year of the 1957
pandemic. Furthermore, analyses of H2N2 and H3N2
viruses isolated from humans between 1957 and 1987
revealed a gradual change in the relative activity of the N2
NA with respect to 3- and 6-linked sialic acids and in the
absolute enzymatic activity [5, 19, 21]. Nevertheless, the
ﬁrst phenotypic changes were observed in viruses from
the early 1960s, whereas NAs of a few tested H2N2 virus
isolates from 1957 appeared to fully retain enzymatic
characteristics of their avian precursor. In this study, we
show for the ﬁrst time that the NA of viruses that caused
the inﬂuenza pandemic in 1957 differed from their putative
avian ancestor by amino acid substitutions in the hemad-
sorption site, lack of hemadsorption activity and reduced
catalytic activity. Substitutions in the different positions of
the hemadsorption site (367, 370, and 400) emerged in
independent N2 lineages (see Fig. 1), suggesting that the
hemadsorption site was under positive selective pressure to
change and that it was destroyed at some time points after
initial avian-to-human transmission when the pandemic
virus started to spread in the human population. Two of the
substitutions, S367N and W400N, only affected the
hemadsorption activity, whereas substitution S370L also
had marginal direct effect on the activity of the catalytic
site as judged by changes in the hydrolysis rate of some
monovalent substrates (Table 1 and ref. [20]). Interest-
ingly, only the lineage with S370L change, that showed the
lowest enzymatic activity against all tested substrates
continued to circulate after the 1957–1958 pandemic,
possibly owing to a better ﬁtness of the NA in humans.
Viruses with the S370L substitution isolated after 1958
accumulated additional mutations in the hemadsorption site
(Fig. 1c). Given that the S370L change was sufﬁcient to
abolish hemadsorption activity, the functional signiﬁcance
of these mutations remains unclear. Because the hemad-
sorption site overlaps with one of the NA antigenic sites
[53], we speculate that these additional mutations in the
HAD site of hemadsorption-negative human NAs could
represent the antigenic drift of the NA.
In contrast to the NA of the 1957 pandemic virus, the
only available sequence of the N1 NA of the 1918 pan-
demic virus [39] shows no substitutions of the six key
amino acids in the hemadsorption site that contact bound
sialic acid. Nevertheless, this NA displayed signiﬁcantly
decreased hemadsorption activity and lowered enzymatic
activity than two avian N1 NAs tested. While further
studies are required to conﬁrm these ﬁndings and specify
their molecular mechanisms, our data suggest that the NA
of A/Brevig Mission/1/18 might have differed already from
its putative avian ancestor in birds.
The role of the viral NA in the virus life cycle is miti-
gation of unfavourable HA interactions with receptors by
removing sialic acids from the mucous blanket, the cell
surface and progeny virions [2, 10, 30, 35]. Because of
their opposing activities, a functional balance between HA
and NA is required to ensure that NA destroys decoy
receptors and inhibitors that can bind to the HA but does
not excessively compromise virus entry into susceptible
cells by premature destruction of functional receptors. This
balance depends on the host- and tissue-speciﬁc patterns of
sialic acid-containing receptors and inhibitors present at the
site of viral replication. The balance between HA and NA
can be disturbed by various events, such as virus trans-
mission to a new host species or gene reassortment with
acquisition of a new HA/NA combination; the resulting
decrease in the viral ﬁtness could be overcome by com-
pensatory mutation of the HA, NA or both proteins (for a
review, see ref. [51]). One can speculate, therefore, that
alteration of the enzymatic activity of the NA of the 1957
pandemic viruses (and likely of the 1918 pandemic viruses)
served to compensate for the changes in the receptor-
binding activity of the viral HA and to convert a virus
originally adapted to the intestinal epithelium of birds [21,
54] to its new environment in the human respiratory tract.
The NA of the third pandemic of the 20th century (H3N2,
1968) originated from the contemporary human H2N2
Hemadsorption activity of inﬂuenza virus neuraminidase 955
123virus, and hence lacked hemadsorption activity and had
signiﬁcantly reduced enzymatic activity [5, 20, 21]. Thus,
in this case the balance seems to have been restored by
acquiring the NA gene directly from a human virus rather
than by a gradual adaptation of an avian virus NA by point
mutations.
Recent human infections by H5N1, H7N7 and H9N2
avian inﬂuenza viruses raise fears of a new pandemic and
highlight the lack of full understanding of adaptive changes
in the avian virus genes required for the emergence of a
pandemic virus [12, 37]. The importance of HA adaptation
for efﬁcient binding to Neu5Ac2-6Gal-terminated recep-
tors in human airway epithelium is well recognized pro-
viding a marker for assessing the pandemic potential of
avian viruses [6, 22, 29, 55]. Our results show that genetic
and functional changes in the NA represent another indi-
cator of ongoing adaptation of avian inﬂuenza viruses to
humans.
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Note added in proof Since the submission of our manuscript, the
new swine-like H1N1 inﬂuenza virus was detected in humans. Our
analysis of available NA sequences (NCBI Inﬂuenza Virus Resource,
GenBank sequences from 2009 H1N1 inﬂuenza outbreak) indicate
that this virus contains a mutation S372N in the NA that likely
reduces or abolishes its hemadsorption activity.
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